KEGG   PATHWAY: map07049Help
Entry
map07049          Drug      Pathway                                

Name
Antithrombosis agents
Class
BRITE hierarchy
Pathway map
Antithrombosis agents
map07049

All organismsOrtholog table
Compound
D00106  
Epoprostenol (USAN/INN)
D00109  
Aspirin (JP16/USP)
D00181  
Argatroban hydrate (JP16)
D00564  
Warfarin sodium (USP)
D00769  
Clopidogrel sulfate (JAN)
D01028  
Ticlopidine hydrochloride (JP16/USAN)
D01029  
Tirofiban hydrochloride (USAN)
D01280  
Warfarin potassium (JP16)
D01337  
Epoprostenol sodium (JAN/USAN)
D01551  
Beraprost sodium (JP16/USAN)
D01624  
Sarpogrelate hydrochloride (JP16)
D01670  
Nafamostat mesilate (JP16)
D01672  
Gabexate mesilate (JP16)
D01684  
Ozagrel sodium (JP16)
D01844  
Fondaparinux sodium (JAN/USAN/INN)
D01896  
Cilostazol (JP16/USAN/INN)
D01981  
Ximelagatran (JAN/USAN/INN)
D02112  
Heparin sodium (JP16/USP/INN)
D02720  
Beraprost (USAN)
D02778  
Abciximab (genetical recombination) (JAN)
D02956  
Anticoagulant heparin (USP)
D02980  
Ardeparin sodium (USAN/INN)
D03136  
Bivalirudin (USAN/INN)
D03213  
Apixaban (JAN/USAN/INN)
D03324  
Nasaruplase (cell culture) (JAN)
D03341  
Urokinase (JP16/USAN/INN)
D03353  
Dalteparin sodium (JAN/USAN/INN)
D03692  
Desirudin (USAN/INN)
D03960  
Aspirin - dialuminate mixt
D04427  
Heparin calcium (JP16/USAN)
D05123  
Nasaruplase beta (USAN/INN)
D06270  
Urokinase alfa (USAN/INN)
D06571  
Antithrombin III human (USP)
D06880  
Lepirudin (INN)
D06888  
Eptifibatide (INN)
D07082  
Dabigatran etexilate methanesulfonate (JAN)
D07086  
Rivaroxaban (JAN/USAN/INN)
D07144  
Dabigatran etexilate (USAN/INN)
D07510  
Adomiparin (USAN)
D07729  
Clopidogrel (INN)
D08004  
Gabexate (INN)
D08327  
Ozagrel (INN)
D08508  
Sarpogrelate (INN)
D08594  
Ticlopidine (INN)
D08607  
Tirofiban (INN)
D08682  
Warfarin (INN)
D08795  
Human anti-thrombin III, freeze-dried concentrated
D09546  
Edoxaban tosilate hydrate (JAN)
D09710  
Edoxaban (USAN/INN)
D09817  
Darexaban maleate (JAN)
Reference
  Authors
Morishima Y, Shibano T
  Title
[Research and development strategy of antithrombotic agents: pharmacology of the  oral factor Xa-inhibitor edoxaban].
  Journal
Nihon Yakurigaku Zasshi 136:83-7 (2010)
Reference
  Authors
Ohmura T, Takahashi I, Ikegami K, Encinas J
  Title
[Pharmacological and clinical profiles of the direct thrombin inhibitor dabigatran etexilate methane sulfate (Prazaxa((R))) ].
  Journal
Nihon Yakurigaku Zasshi 138:79-88 (2011)
Reference
  Authors
Tomiyama Y.
  Title
[Types and their mechanism of action of antiplatelet drugs] (in Japanese)
  Journal
CLINICIAN

DBGET integrated database retrieval system